Skip to content

Sneha Challapilli

NeoMega36® launch

NeoMega36® is the most recent product launched by Neobiomics. It is a Food for Special Medical Purposes, with a nutritional content tailored for preterm infants. It contains Arachidonic acid (ARA) and Docosahexaenoic acid (DHA) which are omega fatty acids, essential for infants. With the product’s… Read More »NeoMega36® launch

Team Neobiomics at the Italian National Conference of Neonatology (SIN) in Naples

Team Neobiomics was thrilled to be participating in a conference in Italy, for the third time! Neobiomics was exhibited at the SIN 2023: 29th Congress of Italian Neonatology Society in Naples and was represented by Dr. Stefan Johansson, CEO and Founder of Neobiomics, and Carla… Read More »Team Neobiomics at the Italian National Conference of Neonatology (SIN) in Naples